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It is well established that the interaction between cancer cells and microenvironment has a critical
role in tumor development, but the roles of miRNAs in this interaction are rarely known. Here, we
have shown that miR-106b is up-regulated in cancer associated ﬁbroblasts compared with normal
ﬁbroblasts established from patients with gastric cancer, the expression level of miR-106b is associ-
ated with poor prognosis of patients, and CAFs with down-regulated miR-106b could signiﬁcantly
inhibit gastric cancer cell migration and invasion by targeting PTEN. Taken together, these data sug-
gest that miR-106b might be a novel candidate target for the treatment of gastric cancer.
 2014 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
Gastric carcinoma is the second most common cause of cancer-
related death in the world and therefore seriously threatens
human health [1,2]. Previous studies have indicated that the initi-
ation and progression of gastric carcinoma was a long and multi-
step process characterized by genetic and epigenetic alterations
of oncogenes and tumor suppressor genes [3], but the exact molec-
ular mechanisms remain unclear.
Recently, it has been increasingly proved that the tumor micro-
environment plays a crucial role in the development and progres-
sion of cancer [4,5]. Co-evolution and ‘‘reprogramming’’ of the
stromal compartments are necessary for human cancer to progressinto advanced stages [6,7]. Stromal interactions with cancer cells in
the microenvironment determine whether cancer cells remain sta-
ble or progress into invasive and metastatic tumors [8–11].
The tumor microenvironment consists of various nonmalignant
cells, such as endothelial cells, ﬁbroblasts, immune cells, inﬂam-
matory cells, and so on. These cells are recruited to transform
tumor cells by acting directly on them and/or releasing active
molecules, such as growth factors and chemokines, which lead to
cancer progression by promoting cell proliferation, inhibiting
apoptosis and stimulating angiogenesis [12]. Cancer associated
ﬁbroblasts (CAFs) make up the major cell types in the tumor
stroma, and reactive CAFs frequently accumulate in gastric cancer
tissues. Furthermore, the prevalence of CAFs is related to certain
clinicopathologic features, such as tumor size and invasive depth,
as well as metastasis of gastric carcinoma [13]. Moreover, CAFs
could stimulate tumor cell growth, migration and invasion, as well
as resistance to chemotherapy [14–16].
MicroRNAs are a novel class of small non-coding regulatory
RNAs that play an important role in various biological processes
including cell division, differentiation, senescence and apoptosis
[17,18]. Accumulating data indicate that microRNAs are involved
in the dramatic changes in tumor microenvironment, particularly
in the CAFs, which may contribute to activate ﬁbroblasts and
induce the progression of human tumor [19].
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of microRNAs in the CAFs obtained from gastric cancer tissues ver-
sus matched normal gastric mucosa ﬁbroblasts, and revealed that
down-regulating miR-106b could signiﬁcantly inhibit gastric can-
cer cell migration and invasion, which was mediated by its directly
targeting the PTEN gene.2. Materials and methods
2.1. Tissue samples and cell lines
We obtained paired samples of tumorous and adjacent normal
tissue from patients with gastric cancer undergoing surgical resec-
tion at Department of General Surgery, Shanghai Tenth Peoples’
Hospital Afﬁliated Tongji University. The protocols were approved
by the Ethics Committee of Shanghai Tenth Peoples’ Hospital for
obtaining all tissue samples. All tissues were obtained from
patients with gastric cancer who had not treated with radiation
therapy or chemotherapy before surgery.
The fresh specimens were washed three times with PBS con-
taining 100 U/ml penicillin and 100 lg/ml streptomycin and cut
into small pieces and digested with collagenase I. Then the mixture
was centrifugated and rinsed the cells with PBS, the pellets were
resuspended in DMEM supplemented with 10% FBS and trans-
ferred to 100 mm dishes. Incubation conditions for CAFs and NFs
were 37 C in humidiﬁed air containing 5% CO2. All cell lines were
used in the experiments were in passage 3.
2.2. Immunoﬂuorescence staining
Primary CAFs and NFs were seeded on coverslips and grown to
80% conﬂuency, ﬁxed in 4% paraformaldehyde for at least 15 min
and permeabilized with 0.2% Triton X-100 in PBS for 5 min at room
temperature. Then cell immunostaining was done with anti-a-SMA
antibody and anti-ﬁbronectin antibody at 4 C. After being rinsed
with PBS, then cells were incubated with secondary FITC-labeled
goat anti-rabbit antibodies. DAPI was added to slides for counter-
stain. Immunoﬂuorescent images were observed and recorded
with a Nikon Eclipse 80i microscope.
2.3. MicroRNA microarray analysis
Total RNA from CAFs and NFs were extracted with the mir-Vana
microRNA Isolation Kit. Then according to protocols by the manu-
facturer, the RNA were labeled and hybridized to Affymetrix micro-
array chips. GC-RMA algorithm was used to normalized raw data
and the signiﬁcance analysis of microarray (SAM) method was
employed to identify differentially expressed genes. The NCode™
Multi-Species microRNA microarray kit V2 was used for analysis
of the arrays. MicroRNAs levels with more than 1.5 folds increase
or decrease changes at P value < 0.05 were considered signiﬁcant
ones and were studied.
2.4. Tissue microarray
Tumor cores obtained from 120 patients with gastric carcinoma
from January 2006 to December 2012 in the Shanghai Tenth Peo-
ple’s Hospital Afﬁliated to Tongji University were used for the tis-
sue microarray. Brieﬂy, after being deparafﬁnized with xylene and
rehydrated with diluted alcohol series, the slides were digested
with proteinase K. Hybridization was done with LNA-modiﬁed
DIG-labeled probes for miR-106b, followed by a stringency wash.
And then after blocking endogenous peroxidase activity, the slides
were incubated in alkaline phosphatase conjugated anti-DIG Fab
fragment solution.Signal ampliﬁcation was done with BCIP/NBT substrate, and
nuclei were counterstained with Nuclear Fast Red. Independent
blinded pathologists scored the intensity of staining with the scale
as followed: negative = 0, weakly positive = 1, moderately posi-
tive = 2 and strongly positive = 3. Patients were dichotomized into
low or high miR-106b expression groups using the median value of
miR-106b as the cutoff point.
2.5. Quantitative Real-time PCR
Total RNA from tissue samples and cell lines were extracted
with TRIzol reagent (Invitrogen, US). Real-time quantitative PCR
was done with Real-time PCR Universal Reagent and the
MX3000P Real-time PCR instrument following the manufacturers’
protocols [20]. All steps were repeated for 3 times.
2.6. Western blotting
Proteins were puriﬁed with the NE-PER Nuclear and Cytoplas-
mic Protein Extraction Reagents Kit (Thermo Scientiﬁc) [20]. In
brief, cells were lysed with lysis buffer and proteins were har-
vested. Proteins were resolved by 10% SDS PAGE and transferred
onto PVDF membranes. The membranes were immunoblotted with
primary antibodies overnight at 4 C, and were incubated with a
secondary antibodies conjugated with HRP. The expression level
of proteins were analyzed with the Lab Work™ Image Acquisition
and Analysis Software (UVP).
2.7. Dual-luciferase activity assay
Dual-luciferase activity assays were performed as previously
described [20]. The 30-UTR mRNA sequences of PTEN gene contain-
ing the miR-106b binding site were ampliﬁed by PCR and cloned
into the Xba1-site of pGL3 vectors. The combination was named
pGL3-PTEN. We also synthesized a pGL3-PTEN-mut construct with
point mutations in the seed sequence using PCR method. All con-
structs were conﬁrmed by DNA sequencing. Then, the cells were
seeded in a 48-well plate and co-transfected with 0.5 lg of miR-
106b inhibitors or control vector, 0.5 lg of pGL3-PTEN or pGL3-
PTEN-mut, and 0.5 lg of a Renilla luciferase expression construct
pRL-TK (Promega, WI) using Lipofectamine 2000. Luciferase activ-
ity was determined with the dual-luciferase reporter assay system
after 48 h transfection, the relative luciferase activity is calculated
as the ratio of Fireﬂy luciferase activity versus Renilla luciferase
activity.
2.8. Cell transfection and co-culture of ﬁbroblasts with gastric cancer
cells
Fibroblasts were transfected with miR-106b inhibitors or con-
trol plasmids with HiPerfect Transfection Reagent based on the
manufacturer’s instructions. Brieﬂy, the cells were seeded onto
plates with complete medium. And the transfection mixture
prepared with serum-free medium, miRNA or control and HiPer-
fect reagent. And then they were incubated at room temperature
and added onto the plates. Cells were incubated with transfection
mixture for 48 h without changing medium change.
For co-culture experiments, gastric cancer cells were seeded at
a density of 1  104 cells per well on the plates and incubated in
the condition media collected from CAFs transfected with miR-
106b inhibitors or empty vector control. The tumor cell growth
was evaluated by MTT assay [20]. Brieﬂy, at the end, gastric cancer
cells were incubated in MTT at 37 C and then lysed in DMSO at
room temperature. Cell viability was estimated as the absorbance
of 580 nm at different time points. All experiments were repeated
for 3 times.
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Gastric carcinoma cells with a density of 1  104 in serum-free
media were seeded in transwell chambers with the Matrigel mem-
brane covered or uncovered and then migration or invasion assay
was performed with the condition media collected from CAFs
transfected with miR-106b inhibitors or empty vector control. Can-
cer cells were ﬁxed with methanol and stained with crystal violet.
The cells which passed through the membrane were counted. All
experiments were repeated for 3 times.
3. Results
3.1. Primary culture and characteristics of CAFs and NFs
The histopathologic grade of gastric cancer tissue sections were
evaluated with H&E staining. The paired CAFs and NFs were iso-
lated from tumor tissues and normal gastric mucosa. We deter-
mined the expression of the ﬁbroblast markers, ﬁbronectin (FN)
and a-smooth muscle actin (SMA) to verify the purity of CAFs
and NFs with immunoﬂuorescence staining. The results showed
that CAFs and NFs were all FN positive. Moreover, CAFs expressed
a high level of a-SMA, which is a biomarker for myoﬁbroblasts, but
not in NFs (Fig. 1A). We have observed increased amounts of ﬁbro-
blast speciﬁc protein 1 (FSP1) and ﬁbroblast activation protein
(FAP), known to be highly expressed in CAFs (Fig. 1B). Hence, we
were able to culture CAFs with high purity from gastric tumor tis-
sues and utilized them in the following assays.
To further analyze the effect of CAFs on gastric cancer cells, we
carried out co-culture experiments to determine the ability of CAFsFig. 1. Characterization of cancer-associated ﬁbroblasts (CAFs) and normal ﬁbroblasts (N
and the adjacent normal gastric mucosa. Fibronectin (FN), the ﬁbroblast biomarker, is uni
of the activate ﬁbroblast is in high level expression in CAFs and weak expression in NF. (B
and anti-Fibroblast Activation Protein (FAP). (C) CAFs stimulate growth of gastric cancer
media from CAFs stimulate gastric cancer cells transwell invasion and migration. Values
were obtained by paired t-test (⁄P < 0.05, ⁄⁄P < 0.01).to promote the growth of gastric cancer cells. The results revealed
that gastric cancer cells co-cultured with CAFs grew faster than
with matched NFs (Fig. 1C). We also performed migration or inva-
sion assays to examine the effects of CAFs on cancer cell motility,
which showed that both migration and invasion capacity of gastric
cancer cells were promoted by CAFs compared with NFs (Fig. 1D).
3.2. MicroRNA proﬁling
Using microarray chips to investigate the microRNA signature
of the CAFs and NFs obtained from human gastric cancer tissues,
we identiﬁed 11 human miRNAs differentially expressed in CAFs
compared with corresponding NFs (Fig. 2A and B). Notably, miR-
34b, miR-93, miR-301a and miR-106b, which have been reported
to stimulate epithelial to mesenchymal transition (EMT) by target-
ing PTEN in invasive endometrial cancer cell lines and promote cell
cycle in gastric cancer through regulating the expression of p21
and E2F5, were signiﬁcantly up-regulated. Another seven miRNA,
including miR-214, which have been indicated to promote gastric
cancer cell proliferation, migration and invasion through regulat-
ing the expression of PTEN gene post-transcriptionally, were sig-
niﬁcantly up-regulated.
3.3. The expression of miR-106b in the gastric cancer stroma
is associated with poor prognosis
The tissue microarray contains samples from 120 resected gas-
tric cancer tissues and was stained for miR-106b using in situ
hybridization. Representative images of stroma histoscore were
shown in Fig. 2C. After separating the patients into groups withFs). (A) The primary cultures of CAFs and NFs were isolated from the tumor tissue
versally expression in CAFs and NFs. a-smooth muscle actin (a-SMA), the biomarker
) Western blot analysis of CAFs and NFs with anti-Fibroblast Speciﬁc Protein 1 (FSP1)
cell line compared to normal ﬁbroblasts in co-culture experiments. (D) Conditioned
in (C and D) represent average numbers for ﬁve pairs of ﬁbroblasts ± S.E.M. P values
Fig. 2. MicroRNA analysis of paired CAFs and NFs. (A) List of microRNAs differentially expressed in CAFs relative to normal ﬁbroblasts. (B) Four of randomly selected
microRNA were analyzed by qRT-PCR in CAFs and NFs derived from gastric cancer patients. Data are shown as fold change between CAFs and NFs. (C) Representative images
of histoscores for miR-106b in situ hybridization in gastric cancer tissues stroma. These cellular compartments were scored as 0 negative, 1 weakly positive, 2 moderately
positive, 3 strongly positive. (D) Kaplan–Meier analysis shows that high miR-106b stromal expression is associated with decreased overall survival (P = 0.03). miR-106b
expression intensity was dichotomized into high versus low based on the median score of all tumors.
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score, the results indicated that high miR-106b stromal expression
were associated with shorter overall survival (P = 0.03, Fig. 2D)
from Kaplan–Meier survival analysis, which suggested that miR-
106b in tumor stroma might be related to the pathological process
of gastric cancer.
3.4. Knockdown of miR-106b in ﬁbroblasts could inhibit the migration
and invasion of gastric cancer cell lines
To investigate the function of miR-106b in ﬁbroblasts, we inves-
tigated whether knockdown of miR-106b in gastric cancer CAFs
could inhibit cancer cell migration and invasion. We transfected
miR-106b inhibitors into CAFs to inhibit the expression of miR-
106b or the control lentiviral vector into CAFs. The conditioned
medium from ﬁbroblasts with low expression of miR-106b could
reduce the migration and invasion of gastric cancer cells (Fig. 3A
and B). However, MTT assay showed that there was no signiﬁcant
difference in growth rates of gastric cancer cells when co-cultured
with CAFs transfected with miR-106b and vector control (Fig. 3D).
3.5. The PTEN 30-untranslated region is a target of miR-106b
The results of luciferase reporter assay showed that co-transfec-
tion of miR-106b inhibitors with the reporter containing PTEN
30UTR could signiﬁcantly decrease the luciferase activity, while
co-transfection with miR-106b inhibitors did not affect the lucifer-
ase activity of the empty vector control (Fig. 4A). In addition, muta-
tions of miR-106b binding site could not reduce luciferase activity
of cells expressing miR-106b inhibitors (Fig. 4B). All these results
indicate that PTEN is a direct target of miR-106b.We further investigated the PTEN protein and mRNA expression
of CAFs transfected with anti-miR-106b or control vector using
Western blotting and quantitative RT-PCR. As shown in Fig. 4C
and D, the PTEN protein expression was signiﬁcantly up-regulated
in cells transfected with anti-miR-106b as compared to the cells
treated with control vector. However, there was no signiﬁcant dif-
ference between the two groups in the expression of PTEN mRNA
(Fig. 4E). All above results demonstrate that PTEN is a target gene
of miR-106b in CAFs.
3.6. Function of PTEN in ﬁbroblasts of gastric cancer
The Western blot analysis conﬁrmed that the expression of
PTEN was lower in CAFs of gastric cancer than in NFs (Fig. 5A
and B). Moreover, we also examined the prognostic value of PTEN
expression in CAFs, the results of Kaplan–Meier analysis indicated
that low expression of PTEN in CAFs was correlated with short sur-
vival time (Fig. 5C and D).
To further evaluate the contribution of PTEN in CAFs or NFs to
gastric cancer cell migration or invasion, we did several experi-
ments using CAFs in which the expression levels of PTEN were
lower than those in NFs. Overexpression of PTEN in CAFs could pro-
mote migration and invasion of gastric cancer cells (Fig. 5E and F).
While the migration and invasion of gastric cancer cells co-cul-
tured with PTEN-depleted NFs were decreased compared with con-
trol vector (Fig. 5G and H).
Our results showed that up-regulation of PTEN expression in
CAFs could signiﬁcantly stimulate gastric cancer cell migration
and invasion, which indicated that down-regulation of miR-106
in CAFs could inhibit migration and invasion of gastric cancer cells
through PTEN-mediated signaling pathway.
Fig. 3. Inhibition of miR-106b expression in CAFs could decreased tumor cell migration and invasion. (A and B) Transfection of anti-miR-106b in CAFs signiﬁcantly decreased
migration and invasion tumor cells in co-cultured experiment. (C) Detection of miR-106b mRNA in CAFs by qRT-PCR using U6 snRNA for normalization. Data are presented as
mean ± S.E.M. Experiments were performed in triplicate and repeated at least three times using CAFs from two different patients. P values were obtained by paired t-test
(⁄P < 0.05, ⁄⁄P < 0.01). (D) Inhibition of miR-106b expression in CAFs do not affect gastric cancer cell growth in co-culture experiments.
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Increasingly more evidence has shown that the initiation and
progression of cancer are related to the interactions between both
tumor and stromal cells in the tumor microenvironment [21]. Can-
cer associated ﬁbroblasts are the most abundant cells in tumor
stroma, and are well known to differ from normal ﬁbroblasts in
their expression proﬁles and behavior, as well as in their inﬂuence
on cancer cells [22,23]. However, the exact molecular mechanism
underlying aberrant expression remains poorly understood.
Several previous studies have suggested that microRNAs play
an important role in regulation of speciﬁc genes present in the cells
of the tumor microenvironment, which plays a vital role in tumor-
igenesis of various human cancer including stomach carcinoma
[24–26]. For instance, Naito et al. [27] have shown that miR-143
is highly expressed in stromal ﬁbroblasts of scirrhous type gastric
cancer, where it may promote tumor progression by regulating theexpression of collagen type III through TGF-b/SMAD signaling
pathway.
Here, we examined whether microRNA expression differed sub-
stantially between NFs and CAFs with gastric cancer and whether
these differences regulated ﬁbroblast behavior. The results of our
present study have revealed that miR-106b was signiﬁcantly up-
regulated in CAFs of gastric cancer, which was previously reported
to be frequently overexpressed in many human malignant tumors,
such as colorectal cancer [28], gastric cancer [29], hepatocellular
carcinoma [30] and head and neck squamous cell carcinomas [31].
In addition, up-regulation of miR-106b was also related to enhanc-
ing theproliferation,migrationand invasionof tumor cells inhuman
cancers. Moreover, our present study indicated that overexpression
of miR-106b in the gastric cancer tissue stroma is associated with
poor prognosis. All these ﬁndings together with those presented
here suggest thatmiR-106bexpression in CAFsmightplay an impor-
tant role in biological process of human gastric cancer.
Fig. 4. PTEN is a direct target of miR-106b. (A and B) Luciferase reporter assay were performed at 48 h post-transfection. CAFs were transfected respectively with the Renilla
luciferase expression construct pRL-TK and pGL3-PTEN-30-UTR ﬁreﬂy luciferase expression construct, along with either anti-miR-106b or control anti-miRNA. Ctr, non-
targeting control; EV, empty vector. Results showed that cells co-transfected with miR-106b and pGL3-PTEN plasmid exhibited a signiﬁcant increase of reporter activity in
comparison with those co-transfected with the control anti-miRNA and pGL3-PTEN plasmid. However, the reporter activity of cells co-transfected with anti-miR-106b and
pGL3-PTEN-mut plasmid showed no signiﬁcant difference with that of cells co-transfected with control microRNA and pGL3-PTEN-mut plasmid. (C and D) The expression
level of PTEN protein was detected byWestern Blot at 48 h post-transfection and normalized to that of b-actin. Results showed that the level of PTEN protein was signiﬁcantly
increased in cells transfected with anti-miR-106b as compared to the cells transfected with control anti-miRNA. (E) The expression level of PTEN mRNA was detected by qRT-
PCR at 48 h posttransfection and normalized to that of GAPDH. Results showed that the expression level of PTEN mRNA exhibited no signiﬁcantly difference between cells
transfected with anti-miR-106b and those transfected with control anti-miRNA. Data represent mean ± S.E.M. from three independent experiments; ⁄P < 0.05 by t test,
⁄⁄P < 0.01 by t test.
T.-S. Yang et al. / FEBS Letters 588 (2014) 2162–2169 2167Interestingly, we have shown that down-regulated miR-106b
expression in CAFs could inhibit gastric cancer cell migration and
invasion in co-culture experiments. In addition, our studies also
revealed that PTEN is regulated by miR-106b through binding of
its 30-UTR, which proved that PTEN is a direct target of miR-
106b. Both miR-106b and PTEN can affect gastric cancer cell migra-
tion and invasion but in opposite directions. Namely, miR-106b
promotes and PTEN inhibits migration and invasion of cancer cells.
Recent studies have shown that miR-106b could regulate
diverse important signaling pathways including PTEN and TGF-b
signaling pathways [32,33], which are also involved in cell cycle
progression mediated by CDKN1A [34] and RB [35]. Here, our
experimental data suggest that down-regulation of miR-106b
expression may inhibit gastric cancer cell migration and invasion
by targeting PTEN.
PTEN was identiﬁed as a tumor suppressor gene, which is
involved in cancer cell proliferation, migration, invasion and apop-
tosis, as well as angiogenesis through several signal pathways
[36,37]. The function of PTEN in tumor cells is extensively studied
but its role in tumor microenvironment is not well-known. Recent
researches have demonstrated that PTEN deﬁciency in mammarystromal ﬁbroblasts of mice could stimulate the progression and
malignant transformation of mammary epithelial tumors by acti-
vating the transcription factor ETS2. They identiﬁed the Pten-
miR-320-Ets2 regulatory axis as a critical stroma-speciﬁc signaling
pathway important in the complicated network of communication
in tumor microenvironment, which was responsible for the patho-
logical molecular events investigated in human mammary tumors
[38,39].
Cancer associated ﬁbroblasts are most important components
of tumor microenvironment in the majority of human cancers,
which secrete various growth factors and chemokines, such as
transforming growth factor-b (TGF-b), hepatocyte growth factor
(HGF), platelet-derived growth factor (PDGF), ﬁbroblast growth
factor-7 (FGF-7), and stromal cell-derived factor-1 (SDF-1) into
the tumor microenvironment that can stimulate tumor cell prolif-
eration, invasion, metastasis and angiogenesis[40–43].
Zhi et al. [13] have previously revealed that the prevalence of
CAFs is closely correlated with the potential of gastric cancer
metastasis. Moreover, TGF-b and FGF-7 produced from ﬁbroblasts
could increase scirrhous gastric cancer cell proliferation and inva-
siveness [42]. Wu et al. [44] also demonstrated that HGF is an
Fig. 5. Up-regulation of PTEN expression in CAFs could inhibit gastric cancer migration and invasion. (A and B) Western blot analysis of PTEN protein expression in ﬁve pairs
of CAFs and NFs, the results shows that the expression of PTEN was signiﬁcantly lower in CAFs than in NFs. (C and D) Representative images of H&E staining histoscores for
PTEN protein in gastric cancer tissues stroma, furthermore, Kaplan–Meier analysis and the log-rank test showed that low expression of PTEN in CAFs predicted poor survival.
(E and F) Transfection of PTEN plasmid in CAFs signiﬁcantly inhibit migration and invasion tumor cells in co-cultured experiment. (G and H) The PTEN expression of NFs was
knockdown by stable expression of lentiviral vector with shPTEN, the results indicated that down-regulation of PTEN in NFs could promote migration and invasion of gastric
cancer cells. Data represent mean ± S.E.M. from three independent experiments; ⁄P < 0.05 by t test, ⁄⁄P < 0.01 by t test.
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genesis in gastric cancer in a paracrine manner. Furthermore, PTEN
signaling is also closely associated with growth factors and chemo-
kines from CAFs. PTEN can modulate glioma response to the inhibi-
tion of HGF/c-Met signaling pathway [45], and PTEN loss ampliﬁes
c-Met-induced glioblastoma malignancy [46]. In addition, PTEN
loss also induces autocrine FGF signaling to promote skin tumori-
genesis [47], and lack of PTEN in osteoprogenitor cells resulted in
increased osteoblast numbers and expanded bone matrix by stim-
ulating FGF signaling [48]. Thus, in our study, up-regulation of PTENexpression in CAFs inhibited gastric cancer cell migration and inva-
sion, which is probablymediated through regulating the expression
and secretion of these growth factors and chemokines.
In summary, our results showed that miR-106b is overexpres-
sed in CAFs of gastric cancer, and knockdown of miR-106b in CAFs
could signiﬁcantly inhibit gastric cancer cell migration and inva-
sion through PTEN-mediated signal pathway, which has not been
reported in previous studies. Based on these ﬁndings, we suggest
that miR-106b in CAFs might be regarded as a new promising ther-
apeutic agent for gastric cancer.
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